Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle

Genes and Development

Volumn 19, Issue 14, 2005, Pages 1715-1722

  Wang, Xiaoxia ^a   Blagden, Chris ^a   Fan, Jihua ^a   Nowak, Scott J ^a   Taniuchi, Ichiro ^a   Littman, Dan R ^a   Burden, Steven J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute myeloid leukemia; Atrophy; Denervation; Hematopoiesis; Myopathy

Indexed keywords

ION CHANNEL; MUSCLE PROTEIN; STRUCTURAL PROTEIN; TRANSCRIPTION FACTOR RUNX1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; ELECTRIC ACTIVITY; GENE IDENTIFICATION; MOUSE; MUSCLE ATROPHY; MUSCLE DENERVATION; MUSCLE FIBRIL; MYOPATHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SKELETAL MUSCLE;

ANIMALS; AUTOPHAGY; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; MALE; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MUSCLE DENERVATION; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOFIBRILS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 23044463578     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1318305     Document Type: Article

References (40)

1. Blagden, C.S., Fromm, L., and Burden, S.J. 2004. Accelerated response of the myogenin gene to denervation in mutant mice lacking phosphorylation of myogenin at threonine 87. Mol. Cell. Biol. 24: 1983-1989.
2. Bodine, S.C., Latres, E., Baumhueter, S., Lai, V.K., Nunez, L., Clarke, B.A., Poueymirou, W.T., Panaro, F.J., Na, E., Dharmarajan, K., et al. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708.
3. Bruning, J.C., Michael, M.D., Winnay, J.N., Hayashi, T., Horsch, D., Accili, D., Goodyear, L.J., and Kahn, C.R. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2: 559-569.
4. Cai, D., Frantz, J.D., Tawa Jr., N.E., Melendez, P.A., Oh, B.C., Lidov, H.G., Hasselgren, P.O., Frontera, W.R., Lee, J., Glass, D.J., et al. 2004. IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell 119: 285-298.
5. de Bruijn, M.F. and Speck, N.A. 2004. Core-binding factors in hematopoiesis and immune function. Oncogene 23: 4238-4248.
6. Drissi, H., Luc, Q., Shakoori, R., Chuva De Sousa Lopes, S., Choi, J.Y., Terry, A., Hu, M., Jones, S., Neil, J.C., Lian, J.B., et al. 2000. Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J. Cell. Physiol. 184: 341-350.
7. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty, G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
8. Durst, K.L. and Hiebert, S.W. 2004. Role of RUNX family members in transcriptional repression and gene silencing. Oncogene 23: 4220-4224.
9. Engel, A.G. 1999. Myofibrillar myopathy. Ann. Neurol. 46: 681-683.
10. Florini, J.R., Ewton, D.Z., and Magri, K.A. 1991. Hormones, growth factors, and myogenic differentiation. Annu. Rev. Physiol. 53: 201-216.
11. Glass, D.J. 2003. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat. Cell. Biol. 5: 87-90.
12. Goldfarb, L.G., Park, K.Y., Cervenakova, L., Gorokhova, S., Lee, H.S., Vasconcelos, O., Nagle, J.W., Semino-Mora, C., Sivakumar, K., and Dalakas, M.C. 1998. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat. Genet. 19: 402-403.
13. Goldspink, G. 1999. Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload. J. Anat. 194: 323-334.
14. Gozuacik, D. and Kimchi, A. 2004. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906.
15. Jagoe, R.T. and Goldberg, A.L. 2001. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr. Opin. Clin. Nutr. Metab. Care 4: 183-190.
16. Klionsky, D.J. and Emr, S.D. 2000. Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721.
17. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R.T., Gao, Y.H., Inada, M., et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
18. Kramer, S.G., Jinks, T.M., Schedl, P., and Gergen, J.P. 1999. Direct activation of Sex-lethal transcription by the Drosophila runt protein. Development 126: 191-200.
19. Munoz-Marmol, A.M., Strasser, G., Isamat, M., Coulombe, P.A., Yang, Y., Roca, X., Vela, E., Mate, J.L., Coll, J., Fernandez-Figueras, M.T., et al. 1998. A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc. Natl. Acad. Sci. 95: 11312-11317.
20. Murgia, M., Serrano, A.L., Calabria, E., Pallafacchina, G., Lomo, T., and Schiaffino, S. 2000. Ras is involved in nerve-activity-dependent regulation of muscle genes. Nat. Cell. Biol. 2: 142-147.
21. Musaro, A., McCullagh, K.J., Naya, F.J., Olson, E.N., and Rosenthal, N. 1999. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400: 581-585.
22. Nguyen, Q.G., Buskin, J.N., Himeda, C.L., Shield, M.A., and Hauschka, S.D. 2003. Differences in the function of three conserved E-boxes of the muscle creatine kinase gene in cultured myocytes and in transgenic mouse skeletal and cardiac muscle. J. Biol. Chem. 278: 46494-46505.
23. Nishino, I. 2003. Autophagic vacuolar myopathies. Curr. Neurol. Neurosci. Rep. 3: 64-69.
24. Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J.E., Oh, S.J., Koga, Y., et al. 2000. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406: 906-910.
25. Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G., and Downing, J.R. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84: 321-330.
26. Parmigiani, G. 2003. The analysis of gene expression data: Methods and software. Springer, New York.
27. Rommel, C., Bodine, S.C., Clarke, B.A., Rossman, R., Nunez, L., Stitt, T.N., Yancopoulos, G.D., and Glass, D.J. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell. Biol. 3: 1009-1013.
28. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S.H., and Goldberg, A.L. 2004. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412.
29. Selcen, D. and Engel, A.G. 2003. Myofibrillar myopathy caused by novel dominant negative α B-crystallin mutations. Ann. Neurol. 54: 804-810.
30. _. 2004. Mutations in myotilin cause myofibrillar myopathy. Neurology 62: 1363-1371.
31. Selcen, D., Ohno, K., and Engel, A.G. 2004. Myofibrillar myopathy: Clinical, morphological and genetic studies in 63 patients. Brain 127: 439-451.
32. Shintani, T. and Klionsky, D.J. 2004. Autophagy in health and disease: A double-edged sword. Science 306: 990-995.
33. Stitt, T.N., Drujan, D., Clarke, B.A., Panaro, F., Timofeyva, Y., Kline, W.O., Gonzalez, M., Yancopoulos, G.D., and Glass, D.J. 2004. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 14: 395-403.
34. Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E.L., Hartmann, D., Lullmann-Rauch, R., Janssen, P.M., Blanz, J., von Figura, K., and Saftig, P. 2000. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406: 902-906.
35. Taniuchi, I. and Littman, D.R. 2004. Epigenetic gene silencing by Runx proteins. Oncogene 23: 4341-4345.
36. Taniuchi, I., Osato, M., Egawa, T., Sunshine, M.J., Bae, S.C., Komori, T., Ito, Y., and Littman, D.R. 2002. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111: 621-633.
37. Ursitti, J.A., Lee, P.C., Resneck, W.G., McNally, M.M., Bowman, A.L., O'Neill, A., Stone, M.R., and Bloch, R.J. 2004. Cloning and characterization of cytokeratins 8 and 19 in adult rat striated muscle. Interaction with the dystrophin glycoprotein complex. J. Biol. Chem. 279: 41830-41838.
38. Vicart, P., Caron, A., Guicheney, P., Li, Z., Prevost, M.C., Faure, A., Chateau, D., Chapon, F., Tome, F., Dupret, J.M., et al. 1998. A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy. Nat. Genet. 20: 92-95.
39. Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A.H., and Speck, N.A. 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. 93: 3444-3449.
40. Zhu, X., Yeadon, J.E., and Burden, S.J. 1994. AML1 is expressed in skeletal muscle and is regulated by innervation. Mol. Cell. Biol. 14: 8051-8057.